NCT02612077已完成不适用
A Cohort Survey of Patients With Metastatic Colorectal Cancer Starting a Chemotherapy in Combination With Avastin®
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 765
- 主要终点
- Progression-free Survival
研究概览
简要总结
This is a longitudinal, multicenter, prospective, pharmacoepidemiological study to evaluate progression free survival (PFS) in a real-life setting in participants with metastatic colorectal cancer (mCRC) starting chemotherapy combined with bevacizumab.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Having colon or rectal metastatic adenocarcinoma, for which the physician decided during the inclusion visit to start a treatment with bevacizumab combined with a 1st, 2nd or 3rd line chemotherapy
- •Having received oral and written information about the survey and not objecting to having his/her data computerized
排除标准
- •Participating in a clinical trial assessing an anticancer treatment
研究组 & 干预措施
Observational Chemotherapy/Bevacizumab
Observed patients receiving chemotherapy with concomitant bevacizumab
干预措施: Observational Chemotherapy (Other)
Observational Chemotherapy/Bevacizumab
Observed patients receiving chemotherapy with concomitant bevacizumab
干预措施: Concomitant Bevacizumab (Drug)
结局指标
主要结局
Progression-free Survival
时间窗: within 36 months
Kaplan Meier estimates of median progression-free survival according to the metastatic line of treatment, for a median follow-up of 18, 15 and 13 months, respectively
次要结局
- Overall Survival(Up to 36 months)
- Quality of Life - Global Health Status(Baseline, 6 and 12 months)
研究者
相似试验
已完成
不适用
Epidemiology and Management of Metastatic Breast CancerBreast Cancer Nos Metastatic RecurrentNCT01711502AstraZeneca128
招募中
不适用
Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinibMetastatic Renal Cell CarcinomaNCT06548867Gruppo Oncologico Italiano di Ricerca Clinica80
招募中
不适用
Longitudinal Study of Local Ablative Therapy in Oligometastatic DiseaseOligometastatic DiseaseMetastasesAblation TechniquesRadiotherapyStereotactic RadiationSurgeryNCT06356779Gitte Fredberg Persson MD PhD1,200
招募中
不适用
A Study to Assess the Ability of Stereotactic Radiotherapy to Restore the Efficacy of Immunotherapy in Patients With Metastatic Cancer.Metastatic CancerNCT06363773Elsan35
已完成
不适用
An Observational Study of Tarceva (Erlotinib) in Patients With Non-Small Cell Lung CancerNon-Squamous Non-Small Cell Lung CancerNCT01488331Hoffmann-La Roche217